When you research the deals that were done recently with other Biotech companies (as in the last year)& mentioned on Page 7 of latest shareholders letter, even before Phase 11(a or b) trials were finished, you clearly get the idea that NN is doing a job on us & probably hopes we stay this naive until they can get their hands on X-Toll.
I think we've been dumbed down when you look at the huge results of these 2 deals reported on these weblinks:
http://www.contractpharma.com/contents/view_breaking-news/2011-06-20/alder-hits-15-million-bms-milestone/
http://www.nature.com/nrd/journal/v9/n1/full/nrd3094.html
http://www.thepharmaletter.com/file/58565/lilly-gains-global-rights-to-incytes-novel-jak1jak2-inhibitor-for-90-million-upfront-and-up-to-665-million-more-deal-with-pdl.html
http://newsroom.lilly.com/releasedetail.cfm?releaseid=431576
http://www.fiercebiotech.com/story/alder-lands-15m-milestone-blockbuster-bms-antibody-deal/2011-06-20
- Forums
- ASX - By Stock
- CBZ
- commercial pharma deals
commercial pharma deals
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CBZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online